Gain insights into the authentic patient experience by listening to one billion patient voices with Pharos Suite

Substantiate your research and make confident decisions with authentic patient experience data

Laptop showing dashboard of the Pharos Suite

Understand the experiences and trajectories of patients in real time

Make patient-focused decisions to demonstrate and optimize the value of treatments

Have you found a reliable and accurate way to understand patients’ reality?

The current research methods at your disposal don’t provide an accurate picture of your patients’ daily lives with their condition. You don’t have access to their experiences, outcomes, burdens, and needs.

It’s frustrating to know that, under the constraints of available resources and current methodologies, you can only get limited results.

We believe you deserve to have access to all the patient trajectories and experiences you need to consistently demonstrate how you positively impact their health

Hear from 1 billion patient voices worldwide

1. Define your target population. Choose the disease, age, location, and any other information you need for your research.

2. Collect data from 1 billion patients worldwide. Have access to a vast patient population to hone in on the aspects that matter to you.

3. Explore patient trajectories in real-time. Use our interactive research platform to dive deep into any aspect of the patient experience and quantify value.

Request a Demo

A systematic approach to evidence generation

Semalytix’s Pharos is an AI-based real world evidence generation tool that ingests data and breaks it down so you can receive specific information about the disease you’re investigating — zooming into specific target populations and studying nearly any variable you are interested in.

With Pharos®, you’re able to make informed decisions that directly impact your treatments’ success and improve your patients’ lives.

Meet Pharos

Largest real-time patient experience data stream on earth

Imagine millions of patient voices at your fingertips

A world-class Machine Reading Artificial Intelligence for Pharma

Patient data stream

Semalytix’s solution processes data from the largest cross-channel online data stream on Earth. Including strategic high-value sources such as Sina Weibo.

Real-time patient insights

Understand patient needs, disease burdens, and treatment experiences on a global scale, in real-time.

Authentic patient voices

The collected data consists of unprompted and undistorted online patient experience data.

Artificial Intelligence for Pharma

The Semalytix Artificial Intelligence has been developed to accurately recognize 1,000,000+ medical concepts and entities in free text.

Multi-lingual AI

The patient data stream captures data in many languages and comes with auto-translation of experience data of 11 European languages, Japanese, and Mandarin providing you with both global and market-specific perspectives.

Vast online target populations

Data collected from the stream is modeled into “online target populations.” So you get access to millions of patient journeys of specific diseases.

Longitudinal analysis

Experience data can be collected through the stream with historic time frame coverage of 2 and up to 10 years, giving you the chance to see trends across time.

Compliance

It is compliant with GDPR regulations, EU guidelines on ethics and trustworthy AI, and developed according to the FDA’s 2019 patient-focused drug development draft guidelines.

Transparency

The platform reports on the accuracy of all algorithms involved, making it really easy for you to interpret findings.

Testimonials

Dr. Jan Brinckmann

"I invested and joined the advisory board of Semalytix because I much enjoyed working with the Semalytix team and saw the huge potential of their solution. I was impressed by their world-leading approach in the field of semantic data analysis which is reflected in a compelling product and a number of outstanding customer references in the pharmaceutical industry. Ever since it has been impressive to see the company grow, advancing their product further, winning new customers and high profile investors. Two thumbs up for the whole Semalytix team!"

Dr. Jan Brinckmann
Professor for Entrepreneurship and Strategy at ESADE

Dr. Ralf Struthoff

"A great, fast-scaling team of world-leading Artificial Intelligence and Semantics experts working with blue-chip clients."Exciting: Separating signal from noise": Semalytix solves the oldest and biggest challenge facing information processing in the billion-dollar pharmaceutical market - and will hopefully do the same for other markets soon."

Dr. Ralf Struthoff
Owner/CEO of Dr. Struthoff GmbH

Oliver Flaskämper

"I am very happy to have the opportunity to join Semalytix as an investor, as I have not encountered a company for quite some time that provides such high customer value. Semalytix will improve the lives of many people, because the company provides answers to pharmaceutical questions related to the efficacy of drugs that, previously could only be answered- if at all - with considerable time and financial investment."

Oliver Flaskämper
Managing Director of Bitcoin Deutschland AG

Eduard R. Dörrenberg

"Generally, I am very happy to support digital ventures, especially local projects such as the ones supported by the Founders Foundation or initiatives from the Pioneers Club. Semalytix is an exciting, regional and digital team with a truly innovative and highly sophisticated approach. The team researches and develops their own technologies based on artificial intelligence. I think that the personal knowledge transfer and the connection with the pharmaceutical industry are particularly well-suited."

Eduard R. Dörrenberg
Managing Director Dr. Kurt Wolff GmbH & Co. KG

Develop products with demonstrable high value for your patients

Without access to real patients, you risk spending years developing a treatment that doesn’t really solve patients’ problems. A drug doctors won’t prescribe.

With Pharos®, you get a thorough understanding of your patients’ needs from every angle. So you can confidently make patient-centric decisions and demonstrate the value of your treatments in improving patients’ lives.